Lilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billion

Eli Lilly & Co. has signed an AI-powered drug development deal with Insilico Medicine that could be worth up to $2.75 billion.


www.bloomberg.com
#Lilly #Insilico #Ink #Deal #Drugs #Worth #Billion